Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum~s disease, hyperpipecolic acidemia, and classical rhizomelic chondrodysplasia punctata are a genetically heterogenous group of lethal inherited diseases collectively referred to as the peroxisome biogenesis disorders (PBD). These diseases occur at a frequency of approximately 1/50,000 live births, can manifest a wide range of phenotypes, and are caused by mutations in any of at least 10 different genes. The only common phenotypes of PBD patients are that they suffer from e=severe mental retardation and exhibit a defect in import of at least one class of peroxisomal protein. Using a yeast genetic system, we and others have identified a number of peroxisome assembly protein (PAS) genes required for normal import of peroxisomal matrix proteins. We recently identified the human gene PXR1 on the basis of its similarity to the yeast Pichia pastoris PAS8 gene. The fact that mutations in PXR1 are responsible for complementation group 2 of the PBD provided the first demonstration that human orthologs of yeast PAS genes are defective in the PBD and proved that yeast PAS sequences can be used to clone human PBD genes. The goal of this project is to identify additional human PBD genes by extension of this homology probing strategy. We propose to expand our current molecular analysis of peroxisome assembly in Pichia pastoris in order to identify all genes involved in proxisomal protein import and peroxisome assembly in this yeast. We will study these new yeast PAS genes, proteins and mutants to gain a better understanding of the peroxisome assembly process and use the sequence of these new PAS genes to determine the role of two candidate human PBD genes (PXAAA1 and PXSH3) in peroxisome assembly and human disease.

Project Start
1999-01-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Hugo W. Moser Research Institute Kennedy Krieger
Department
Type
DUNS #
167202410
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Brose, Rebecca Deering; Shin, Gloria; McGuinness, Martina C et al. (2012) Activation of the stress proteome as a mechanism for small molecule therapeutics. Hum Mol Genet 21:4237-52
Brose, Rebecca Deering; Avramopoulos, Dimitri; Smith, Kirby D (2012) SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes. J Neurol 259:1440-7
Steinberg, S J; Snowden, A; Braverman, N E et al. (2009) A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis 32:109-19
Jia, Zhenzhen; Pei, Zhengtong; Maiguel, Dony et al. (2007) The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers? J Mol Neurosci 33:25-31
Watkins, Paul A; Maiguel, Dony; Jia, Zhenzhen et al. (2007) Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res 48:2736-50
Jia, Zhenzhen; Moulson, Casey L; Pei, Zhengtong et al. (2007) Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 282:20573-83
Eichler, Florian; Mahmood, Asif; Loes, Daniel et al. (2007) Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 64:659-64
Lu, Jyh-Feng; Barron-Casella, Emily; Deering, Rebecca et al. (2007) The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage. Lab Invest 87:261-72
Moser, Hugo W; Mahmood, Asif; Raymond, Gerald V (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3:140-51
Moser, Hugo W (2006) Therapy of X-linked adrenoleukodystrophy. NeuroRx 3:246-53

Showing the most recent 10 out of 167 publications